Company / Operating Income
Praxis Precision Medicines, Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$326.2M
FY2025
5-year range
-$326.2M / -$126.4M
FY2021-FY2025
Trend
-63.0%
vs FY2024
Sector context
#168 of 204
Health Care
What the data says
Praxis Precision Medicines, Inc.'s operating income of -$326M is lower than 82% of companies in the Health Care sector (FY2025). Declined from -$126M to -$326M over the past 2 years.
Based on SEC 10-K filings.
-$326M in FY2025.
Declined from -$126M to -$326M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 204This company -$326.2M Sector average $107.7M
▼
-402.8% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 63.0% year-over-year.
- Ranks #168 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$326.2M | -63.0% |
| FY2024 | -$200.2M | -58.4% |
| FY2023 | -$126.4M | +41.2% |
| FY2022 | -$215.0M | -28.5% |
| FY2021 | -$167.3M | -170.0% |
| FY2020 | -$62.0M | -73.1% |
| FY2019 | -$35.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026